Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Actavis plc (ACT)

-NYSE
214.26 Down 1.29(0.60%) 4:02PM EDT
|After Hours : 213.00 Down 1.26 (0.59%) 5:52PM EDT - Nasdaq Real Time Price
Prev Close:215.55
Open:213.14
Bid:213.00 x 800
Ask:214.90 x 200
1y Target Est:262.25
Beta:0.32
Next Earnings Date: 5-Aug-14ACT Earnings announcement
Day's Range:210.78 - 214.80
52wk Range:130.06 - 230.77
Volume:3,033,499
Avg Vol (3m):2,137,370
Market Cap:37.38B
P/E (ttm):N/A
EPS (ttm):-3.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTDown 0.60%37.38B
MYLDown 2.33%18.45B
NVSDown 1.70%210.93B
TEVADown 2.51%45.51B

Key Statistics

Forward P/E (1 yr):12.90
P/S (ttm):3.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.59
Quarterly EPS Est (Jun-14) :3.36
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback